Prevalence of HIV infection among ex-prisoners in England
Paul J Turnbull, Gerry V Stimson, Kate A Dolan Discussions about HIV and AIDS in prisons have been hampered by the lack of data on the prevalence of HIV among prisoners and on their risk behaviour.' We present results from a survey of HIV infection in people recently released from prison.
Subjects, methods, and results
In 1990 we recruited 452 ex-prisoners in England who were contacted within three months of release from prison. A structured interview was administered covering sexual and drug injecting behaviour before, during, and after imprisonment and experiences of imprisonment. Saliva samples were collected by use of a salivette and tested for HIV antibodies by GACRIA and GACELISA,2 thus providing an estimate of the HIV status of the sample when in prison.
The sample included 168 Patients, methods, and results Eight consenting adults (seven men and one woman) with lepromatous leprosy (five patients) or borderline lepromatous leprosy (three) who had been previously untreated (six) or whose leprosy had relapsed (two) were treated with 100 mg minocycline alone once daily for three months.
After one week's treatment we observed improvement in either skin erythema or induration in six patients and improvement in both manifestations in two. After three months' treatment skin lesions had noticeably improved in all patients, six patients having complete resolution of all erythema and induration. One patient had mild transient vertigo, which resolved spontaneously without discontinuing treatment. No other adverse reaction was noted. Unexpectedly, none of the patients developed a lepra reaction.
Before treatment and at one week and one, two, and three months after starting treatment skin biopsies were performed, from which 5 x 103 M leprae were inoculated into the hind feet of BALB/c mice. If more than 10' acid fast bacilli per foot pad were found in pooled foot pads (four) harvested eight and 12 months subsequently or in one foot pad or more of those (generally 10) counted individually 12 months after infection, viable bacilli were considered to have been present in the inoculum.
All of the pretreatment skin biopsy specimens consistently resulted in growth of the bacilli in mice when evaluated by both methods. According to the findings of pooled harvests of foot pads no patient harboured any viable M leprae at either two or three months after starting treatment (table) . Harvests of individual foot pads were more sensitive in detecting any viable M leprae; in six instances these results were positive and those of pooled harvests were negative, and in none was the opposite true (table). Viable bacilli were consistently absent from the skin in only one patient at one week after treatment. At one and two months respectively three and six of the patients had lost detectable viable leprosy bacilli, and by three months none of the eight patients harboured any viable bacilli.
Serum minocycline concentrations determined by an agar disc diffusion method2 were at the peak (two hours after treatment) 1 84 (SD 0 48) mg/l (range 1 07-2-66 mg/i) and at the trough (24 
Comment
The consistent rapidity of the patients' clinical response to minocycline is unique in our experience. 
